Morgan Stanley’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.8K Sell
2,650
-1,625
-38% -$16.8K ﹤0.01% 6714
2025
Q4
$50.4K Buy
4,275
+3,937
+1,165% +$34K ﹤0.01% 6436
2025
Q3
$2.71K Buy
338
+12
+4% +$84 ﹤0.01% 7239
2025
Q2
$2.61K Sell
326
-15
-4% -$110 ﹤0.01% 7170
2025
Q1
$2.41K Sell
341
-40,281
-99% -$435K ﹤0.01% 7136
2024
Q4
$461K Buy
40,622
+39,950
+5,945% +$520K ﹤0.01% 5446
2024
Q3
$9.41K Hold
672
﹤0.01% 6733
2024
Q2
$10.7K Sell
672
-20
-3% -$489 ﹤0.01% 6662
2024
Q1
$18.7K Sell
692
-692
-50% -$16.6K ﹤0.01% 6511
2023
Q4
$27.9K Sell
1,384
-7,462
-84% -$103K ﹤0.01% 6547
2023
Q3
$116K Buy
8,846
+3,286
+59% +$54K ﹤0.01% 5817
2023
Q2
$105K Sell
5,560
-7,999
-59% -$158K ﹤0.01% 5936
2023
Q1
$260K Buy
13,559
+11,691
+626% +$317K ﹤0.01% 5585
2022
Q4
$51.6K Sell
1,868
-23,255
-93% -$587K ﹤0.01% 6278
2022
Q3
$629K Sell
25,123
-27,425
-52% -$1.08M ﹤0.01% 5147
2022
Q2
$2.48M Buy
52,548
+19,377
+58% +$905K ﹤0.01% 4364
2022
Q1
$2.06M Sell
33,171
-44,434
-57% -$3.66M ﹤0.01% 4505
2021
Q4
$9.86M Buy
77,605
+20,433
+36% +$3.34M ﹤0.01% 2969
2021
Q3
$11.4M Sell
57,172
-145
-0.3% -$34.6K ﹤0.01% 2744
2021
Q2
$15.2M Buy
57,317
+27,027
+89% +$8.36M ﹤0.01% 2489
2021
Q1
$10.6M Buy
30,290
+9,073
+43% +$3.87M ﹤0.01% 2580
2020
Q4
$10.9M Buy
21,217
+738
+4% +$296K ﹤0.01% 2427
2020
Q3
$5.37M Buy
20,479
+871
+4% +$300K ﹤0.01% 2658
2020
Q2
$10.7M Buy
19,608
+4,975
+34% +$2.24M ﹤0.01% 1903
2020
Q1
$4.61M Buy
+14,633
New +$4.58M ﹤0.01% 2535

Other funds holding PASG